Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Polymorphisms in MMP9 and SIPA1 are associated with increased risk of nodal metastases in early-stage cervical cancer.

Brooks R, Kizer N, Nguyen L, Jaishuen A, Wanat K, Nugent E, Grigsby P, Allsworth JE, Rader JS.

Gynecol Oncol. 2010 Mar;116(3):539-43. doi: 10.1016/j.ygyno.2009.09.037. Epub 2009 Nov 10.

2.

Polymorphisms of the SIPA1 gene and sporadic breast cancer susceptibility.

Hsieh SM, Smith RA, Lintell NA, Hunter KW, Griffiths LR.

BMC Cancer. 2009 Sep 18;9:331. doi: 10.1186/1471-2407-9-331.

3.

Case-only analyses of the associations between polymorphisms in the metastasis-modifying genes BRMS1 and SIPA1 and breast tumor characteristics, lymph node metastasis, and survival.

Roberts MR, Hong CC, Edge SB, Yao S, Bshara W, Higgins MJ, Freudenheim JL, Ambrosone CB.

Breast Cancer Res Treat. 2013 Jun;139(3):873-85. doi: 10.1007/s10549-013-2601-3. Epub 2013 Jun 16.

4.

The association of SIPA1 gene polymorphisms with breast cancer risk: evidence from published studies.

Yi SM, Li GY.

Tumour Biol. 2014 Jan;35(1):441-5. doi: 10.1007/s13277-013-1061-z. Epub 2013 Sep 5.

PMID:
24006220
5.

Genetic variation in SIPA1 in relation to breast cancer risk and survival after breast cancer diagnosis.

Gaudet MM, Hunter K, Pharoah P, Dunning AM, Driver K, Lissowska J, Sherman M, Peplonska B, Brinton LA, Chanock S, Garcia-Closas M.

Int J Cancer. 2009 Apr 1;124(7):1716-20. doi: 10.1002/ijc.23919.

6.

Germline polymorphisms in SIPA1 are associated with metastasis and other indicators of poor prognosis in breast cancer.

Crawford NP, Ziogas A, Peel DJ, Hess J, Anton-Culver H, Hunter KW.

Breast Cancer Res. 2006;8(2):R16. Epub 2006 Mar 21.

7.

Sipa1 promoter polymorphism predicts risk and metastasis of lung cancer in Chinese.

Xie C, Yang L, Yang X, Yang R, Li Y, Qiu F, Chen M, Fang W, Bin X, Deng J, Huang D, Liu B, Zhou Y, Lu J.

Mol Carcinog. 2013 Nov;52 Suppl 1:E110-7. doi: 10.1002/mc.22039. Epub 2013 May 9.

PMID:
23661532
8.

Distinct inherited metastasis susceptibility exists for different breast cancer subtypes: a prognosis study.

Hsieh SM, Look MP, Sieuwerts AM, Foekens JA, Hunter KW.

Breast Cancer Res. 2009;11(5):R75. doi: 10.1186/bcr2412. Epub .

9.

Association of SIPA1 545 C > T polymorphism with survival in Chinese women with metastatic breast cancer.

Pei R, Xu Y, Wei Y, Ouyang T, Li J, Wang T, Fan Z, Fan T, Lin B, Xie Y.

Front Med. 2013 Mar;7(1):138-42. doi: 10.1007/s11684-013-0247-5. Epub 2013 Jan 28.

PMID:
23358895
10.

Influence of quantity of lymph-vascular space invasion on the risk of nodal metastases in women with early-stage squamous cancer of the cervix.

Roman LD, Felix JC, Muderspach LI, Varkey T, Burnett AF, Qian D, Morrow CP.

Gynecol Oncol. 1998 Mar;68(3):220-5.

PMID:
9570969
11.
12.
13.

SCC-Ag, lymph node metastases and sentinel node procedure in early stage squamous cell cervical cancer.

van de Lande J, Davelaar EM, von Mensdorff-Pouilly S, Water TJ, Berkhof J, van Baal WM, Kenemans P, Verheijen RH.

Gynecol Oncol. 2009 Jan;112(1):119-25. doi: 10.1016/j.ygyno.2008.09.042. Epub 2008 Nov 12.

PMID:
19007978
14.

The SIPA1 -313A>G polymorphism is associated with prognosis in inoperable non-small cell lung cancer.

Gdowicz-Kłosok A, Giglok M, Drosik A, Suwiński R, Butkiewicz D.

Tumour Biol. 2015 Feb;36(2):1273-8. doi: 10.1007/s13277-014-2753-8. Epub 2014 Oct 29.

PMID:
25352027
15.

Extent of lymphovascular space invasion and risk of pelvic lymph node metastases in stage IB1 cervical cancer.

Chandacham A, Charoenkwan K, Siriaunkgul S, Srisomboon J, Suprasert P, Phongnarisorn C, Cheewakraingkrai C, Siriaree S, Tantipalakorn C, Kietpeerakool C.

J Med Assoc Thai. 2005 Oct;88 Suppl 2:S31-6.

PMID:
17722314
16.
17.

Is common iliac lymph node dissection necessary in early stage cervical carcinoma?

Siu SS, Cheung TH, Lo KW, Yim SF, Chung TK.

Gynecol Oncol. 2006 Oct;103(1):58-61. Epub 2006 Feb 21.

PMID:
16490238
18.
19.

Sentinel lymph node biopsy vs. pelvic lymphadenectomy in early stage cervical cancer: is it time to change the gold standard?

Gortzak-Uzan L, Jimenez W, Nofech-Mozes S, Ismiil N, Khalifa MA, Dubé V, Rosen B, Murphy J, Laframboise S, Covens A.

Gynecol Oncol. 2010 Jan;116(1):28-32. doi: 10.1016/j.ygyno.2009.10.049. Epub 2009 Oct 28.

PMID:
19875161
20.

18F-FDG PET/CT can predict nodal metastases but not recurrence in early stage uterine cervical cancer.

Crivellaro C, Signorelli M, Guerra L, De Ponti E, Buda A, Dolci C, Pirovano C, Todde S, Fruscio R, Messa C.

Gynecol Oncol. 2012 Oct;127(1):131-5. doi: 10.1016/j.ygyno.2012.06.041. Epub 2012 Jul 6.

PMID:
22772064
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk